Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

glycan/inflamació

L'enllaç es desa al porta-retalls
15 resultats

Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION Inflammatory bowel disease (IBD), including Intestinal Colitis, Crohn's Disease (CD) and Ulcerative Colitis (UC), involves chronic inflammation of all or part of the digestive tract. Intestinal Colitis involves non-specific inflammation of the intestine. CD involves

Method for diagnosing and prognosing inflammatory bowel disease and crohn's disease

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
RELATED APPLICATIONS This application claims the benefit of, and priority to, U.S. Ser. No. 10/843,033, filed May 11, 2004, which in turn claims the benefit of, and priority to, U.S. Ser. No. 10/728,227, filed Dec. 3, 2003. The contents of these applications are incorporated by reference in their

Method for the analysis of N-glycans attached to immunoglobulin G from human blood plasma and its use

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS REFERENCE TO RELATED APPLICATIONS This application is the U.S. National Phase Application of PCT/HR2014/000022, filed Jun. 11, 2014, which claims priority to Croatian Patent Application No. P20130568A, filed Jun. 20, 2013, the contents of such applications being incorporated by reference

Glycan-based drugs, therapies and biomarkers

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF INVENTION The present disclosure relates generally to the fields of biology, medicine and epidemiology, and in particular, to one or more processes for diagnosing, preventing and/or treating infectious diseases, cancers, autoimmune diseases, allergies, toxicity, obesity and/or other

Glycan-based drugs, therapies and biomarkers

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF INVENTION The present disclosure relates generally to the fields of biology, medicine and epidemiology, and in particular, to one or more processes for diagnosing, preventing and/or treating infectious diseases, cancers, autoimmune diseases, allergies, toxicity, obesity and/or other

Technetium-99m labeled peptides for imaging inflammation

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to compositions that are radiolabeled scintigraphic imaging agents, methods of using these compositions and methods for producing such radiolabeled compositions. Specifically, the invention relates to technetium-99m labeled

Technetium-99m labeled peptides for imaging inflammation

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to compositions that are radiolabeled scintigraphic imaging agents, methods of using these compositions and methods for producing such radiolabeled compositions. Specifically, the invention relates to technetium-99m labeled

Technetium-99M labeled peptides for imaging inflammation

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to compositions that are radiolabeled scintigraphic imaging agents, methods of using these compositions and methods for producing such radiolabeled compositions. Specifically, the invention relates to technetium-99m labeled

Glycosulfopeptide inhibitors of leukocyte rolling and methods of use thereof

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND The present invention is directed to glycosulfopeptides and methods of their use in treating inflammation and disorders related to leukocyte rolling mediated by P-selectin binding. Inflammation is the reaction of vascularized tissue to local injury. This injury can have a variety of

Synthetic glycosulfopeptides and methods of synthesis thereof

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND The present invention is directed to glycosulfopeptides, methods of their synthesis, and methods of their use in treating inflammation. Inflammation is the reaction of vascularized tissue to local injury. This injury can have a variety of causes, including infections and direct physical

Synthetic glycosulfopeptides and methods of synthesis thereof

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND The present invention is directed to glycosulfopeptides, methods of their synthesis, and methods of their use in treating inflammation. Inflammation is the reaction of vascularized tissue to local injury. This injury can have a variety of causes, including infections and direct physical

Synthetic glycosulfopeptides and methods of synthesis thereof

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND The present invention is directed to glycosulfopeptides, methods of their synthesis, and methods of their use in treating inflammation. Inflammation is the reaction of vascularized tissue to local injury. This injury can have a variety of causes, including infections and direct physical

Synthetic glycosulfopeptides and methods of synthesis thereof

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND The present invention is directed to glycosulfopeptides, methods of their synthesis, and methods of their use in treating inflammation. Inflammation is the reaction of vascularized tissue to local injury. This injury can have a variety of causes, including infections and direct physical

Synthetic multivalent sLe.sup.x containing polylactosamines and methods for use

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION The present invention is directed to novel compositions and their use in the treatment of inflammatory responses. Specifically, the invention is directed to novel synthetic oligosaccharide constructs, especially multiple sLe.sup.x decorated poly-N-acetyllactosamines and their

Calcium and magnesium complexes of phytohemagglutinin-polyheteroglycans, their preparation and pharmaceutical formulations

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The present invention relates to new calcium and magnesium complexes of phytohemagglutinin-polyheteroglycans of plant origin, to a process for their preparation, and to pharmaceutical formulations which contain these complexes as active compound. The essential constituents of the new complexes are
Uneix-te a la nostra
pàgina de Facebook

La base de dades d’herbes medicinals més completa avalada per la ciència

  • Funciona en 55 idiomes
  • Cures a base d'herbes recolzades per la ciència
  • Reconeixement d’herbes per imatge
  • Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
  • Llegiu publicacions científiques relacionades amb la vostra cerca
  • Cerqueu herbes medicinals pels seus efectes
  • Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades

Google Play badgeApp Store badge